Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$14.43
-3.5%
$12.33
$8.89
$24.50
$625.63MN/A481,725 shs359,902 shs
LivaNova PLC stock logo
LIVN
LivaNova
$42.79
-2.8%
$38.93
$32.48
$61.94
$2.33B0.84651,905 shs513,422 shs
NovoCure Limited stock logo
NVCR
NovoCure
$19.37
+1.0%
$17.51
$14.17
$34.13
$2.16B0.731.14 million shs873,347 shs
Warby Parker Inc. stock logo
WRBY
Warby Parker
$20.10
-2.4%
$17.01
$12.46
$28.68
$2.10B2.011.91 million shs1.89 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
+3.60%-5.62%+36.41%-25.21%+1,494,999,900.00%
LivaNova PLC stock logo
LIVN
LivaNova
+5.11%-1.92%+18.14%+6.20%-26.14%
NovoCure Limited stock logo
NVCR
NovoCure
+3.45%+5.38%+3.68%-12.66%-17.15%
Warby Parker Inc. stock logo
WRBY
Warby Parker
+3.43%+0.49%+32.39%-13.38%+18.96%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/AN/AN/AN/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
3.8203 of 5 stars
4.53.00.00.03.51.71.3
NovoCure Limited stock logo
NVCR
NovoCure
3.7962 of 5 stars
3.32.00.04.53.41.70.0
Warby Parker Inc. stock logo
WRBY
Warby Parker
3.1588 of 5 stars
3.32.00.00.03.94.20.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
2.78
Moderate Buy$24.8372.10% Upside
LivaNova PLC stock logo
LIVN
LivaNova
3.00
Buy$59.2938.55% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.67
Moderate Buy$32.8369.51% Upside
Warby Parker Inc. stock logo
WRBY
Warby Parker
2.61
Moderate Buy$22.5612.25% Upside

Current Analyst Ratings Breakdown

Latest BBNX, LIVN, WRBY, and NVCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/22/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$18.00 ➝ $21.00
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$17.00 ➝ $22.00
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$18.00 ➝ $21.00
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $24.00
5/20/2025
LivaNova PLC stock logo
LIVN
LivaNova
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$60.00
5/13/2025
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$64.00 ➝ $64.00
5/13/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$23.00 ➝ $20.00
5/9/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$18.00 ➝ $20.00
5/9/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$30.00 ➝ $22.00
(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$69.83M8.96N/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
$1.28B1.83$3.84 per share11.15$23.72 per share1.80
NovoCure Limited stock logo
NVCR
NovoCure
$621.71M3.47N/AN/A$3.39 per share5.71
Warby Parker Inc. stock logo
WRBY
Warby Parker
$795.09M2.64N/AN/A$3.08 per share6.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/AN/A0.00N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M-$4.09101.8813.63N/A1.91%13.81%7.07%7/30/2025 (Estimated)
NovoCure Limited stock logo
NVCR
NovoCure
-$207.04M-$1.51N/AN/AN/A-25.93%-41.48%-12.74%7/24/2025 (Estimated)
Warby Parker Inc. stock logo
WRBY
Warby Parker
-$63.20M-$0.12N/A201.00N/A-4.39%-8.26%-4.37%8/14/2025 (Estimated)

Latest BBNX, LIVN, WRBY, and NVCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.51-$0.52-$0.01-$0.93N/AN/A
4/24/2025Q1 2025
NovoCure Limited stock logo
NVCR
NovoCure
-$0.47-$0.31+$0.16-$0.31$147.57 million$154.99 million
3/25/2025Q4 2024
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.42-$1.82-$1.40-$2.72$20.01 million$20.44 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
0.46
3.37
2.87
NovoCure Limited stock logo
NVCR
NovoCure
0.27
1.49
1.44
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/A
2.47
2.06

Institutional Ownership

CompanyInstitutional Ownership
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Warby Parker Inc. stock logo
WRBY
Warby Parker
93.24%

Insider Ownership

CompanyInsider Ownership
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
LivaNova PLC stock logo
LIVN
LivaNova
0.29%
NovoCure Limited stock logo
NVCR
NovoCure
6.29%
Warby Parker Inc. stock logo
WRBY
Warby Parker
26.55%
CompanyEmployeesShares OutstandingFree FloatOptionable
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
29443.36 millionN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
2,90054.53 million54.15 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,320111.49 million101.40 millionOptionable
Warby Parker Inc. stock logo
WRBY
Warby Parker
3,030104.50 million74.67 millionOptionable

Recent News About These Companies

FY2026 EPS Estimate for Warby Parker Increased by Analyst
Q3 Earnings Forecast for Warby Parker Issued By Roth Capital
Warby Parker teams with Google. Is the stock a buy?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Beta Bionics stock logo

Beta Bionics NASDAQ:BBNX

$14.43 -0.52 (-3.48%)
As of 04:00 PM Eastern

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$42.79 -1.23 (-2.79%)
Closing price 04:00 PM Eastern
Extended Trading
$42.78 -0.01 (-0.01%)
As of 05:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$19.37 +0.19 (+0.99%)
Closing price 04:00 PM Eastern
Extended Trading
$19.65 +0.28 (+1.44%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Warby Parker stock logo

Warby Parker NYSE:WRBY

$20.10 -0.49 (-2.38%)
Closing price 03:59 PM Eastern
Extended Trading
$20.48 +0.38 (+1.89%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.